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Seven papers delivered at a symposium held at 
Delft in October 1982 are collected in this volume. 
There are contributions on India, Africa and Latin 
America; case studies on vaccine production and 
on the use of clonal oil palms; views from a de- 
veloped donor country (The Netherlands) and 
from the developing countries. 
The picture is inevitably representative rather 
than complete; but this reasonably priced, soft- 
backed, photo-offset volume does give an excellent 
snapshot of the vast opportunities and difficulties 
that the use of biotechnology presents to the de- 
veloping world. 
The chapter by Edgar da Silva of UNESCO 
giving the developing countries’ view emphasises 
that for successful sustained development he de- 
veloping countries must themselves be responsible 
for whatever is done. 
There is no room for a ‘naive and charitable’ 
approach (for the developed world) promoted by 
“trendy and elite groups that have been caught up 
in their self-appointed roles of charitable develop- 
ment”. UNESCO’s approach is to support self- 
reliance, and its efforts in this direction, through 
the building of institutional networks are well 
described. 
The main input to be made by the donor coun- 
tries is identified in J.W.M. la I&i&e’s contribu- 
tion as in training. 
October 1984 
The papers on India, Africa and Latin America 
illustrate some of the successes as well as some of 
the practical problems impeding progress. As an 
outsider it seems to me that some of the problems 
are being exacerbated by a too ready tendency to 
address the obvious targets such as fuel alcohol 
production. However, if that criticism is valid the 
UNESCO view is that this will become obvious to 
the developers themselves in the course of a learning 
process. It may not be valid everywhere. After all, 
some of the West’s important technologies, for ex- 
ample the Haber ammonia process, were obvious 
development argets pursued for strategic reasons 
and only became economic after decades of de- 
velopment. 
The case study on vaccine production shows that 
it has still not been possible to transfer this rather 
sophisticated technology to the developing world 
and concludes that the immediate prospects for 
such a transfer are still rather limited. In contrast 
the case study on the use of clonal oil palms shows 
how, in this field at least, a successful relationship 
has been developed between one (rapidly) de- 
veloping country, Malaysia, and the UK. 
This little volume is well worth reading. 
Ken Sargeant 
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